@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix rgd: . @prefix proteinModification: . @prefix psimod: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf rgd:2869; a proteinModification:, psimod:00696 . sub:_2 occursIn: mesh:D006321, mesh:D032389, species:10116; rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject chebi:5586; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:\"hydrogen peroxide\") -> p(RGD:Igf1r,pmod(P,Y))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "H2O2 treatment of A10 VSMCs enhanced tyrosine phosphorylation of the IGF-1R?-subunit, which was blocked by AG 1024 (33)."; prov:wasQuotedFrom pubmed:17406055 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17406055; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:50.364+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }